Companies: 10,795·Total market cap: $144.5T

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA.TOTSXHealthcare● Active

$16.29

+$0.08(+0.49%)

Market Cap$3.8B

P/E Ratio—

52W High$16.92

52W Low$0.99

Avg Volume826K

Open$16.20

Beta1.64

Net Income Financials Revenue

Curaleaf Holdings, Inc. (CURA.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CURA.TO · net income · updated Jun 8, 2026

Core profitability metrics

CURA.TO · net income · margin · TTM · CAGR

Net income was −$235.1M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. Net profit margin was -18.2%.

FY2025 Net Income−$235.1M▼ -9.1% YoY

Trailing 12M (TTM)−$114.1Mtrailing 4 quarters sum

Net Profit Margin-18.2%−$235.1M ÷ $1.29B

YoY Change-9.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · CURA.TO net income history · CURA.TO profit margin

Annual net income data

CURA.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$235.1M▼ 9.1%-18.2%$1.29B

FY2024Loss−$215.4M▲ +23.4%-16.0%$1.34B

FY2023Loss−$281.2M▲ +25.4%-20.9%$1.35B

FY2022Loss−$376.9M▼ 245.4%-28.2%$1.34B

FY2021Loss−$109.1M▼ 77.9%-9.0%$1.21B

Net income vs peers (Healthcare)

CURA.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Curaleaf Holdings, Inc.YOU

CURA.TO

−$235.1M-9.1%-18.2%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Curaleaf Holdings, Inc. (CURA.TO) reported net income of −$235.1M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. The net profit margin was -18.2% — meaning the company kept $-0.18 of every dollar of revenue as profit.

Curaleaf Holdings, Inc. has not yet achieved annual profitability based on available data (12 fiscal years). The company has reported net losses across all available periods.

Curaleaf Holdings, Inc.'s net profit margin was -18.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Curaleaf Holdings, Inc. net worth" — the company's market capitalization is a separate figure from CURA.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CURA.TO net income · 4 questions

Curaleaf Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $235.1M for FY2025.

is CURA.TO profitabledoes CURA.TO make a profitCURA.TO profitabilityCURA.TO profitable company

▸ Source: FMP /income-statement · GAAP · Curaleaf Holdings, Inc. · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026